Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anthony T Newall

Showing results (11-20 of 69) with videos related to

Pageof 7
Sort By:
Vaccine|July 14, 2012
Under-explored assumptions in influenza vaccination models: implications for the universal vaccination of childrenAnthony T Newall, Juan Pablo Dehollain, James G Wood
Pharmacoeconomics|July 31, 2009
Cost effectiveness of influenza vaccination in older adults: a critical review of economic evaluations for the 50- to 64-year age groupAnthony T Newall, Heath Kelly, Stuart Harsley, et al.
Vaccine|December 14, 2011
The cost and disease burden of pneumonia in general practice in AustraliaAmbrose Li, Anthony T Newall, Helena Britt, et al.
Vaccine|November 8, 2025
Effectiveness of maternal vaccines and long-acting monoclonal antibodies against respiratory syncytial virus disease burden in early life: a scoping review of dynamic modelling studiesAlessandra Bicego, James G Wood, Anthony T Newall, et al.
Plos One|September 12, 2013
Contact tracing of tuberculosis: a systematic review of transmission modelling studiesMatt Begun, Anthony T Newall, Guy B Marks, et al.
Emerging Infectious Diseases|February 2, 2010
Cost-effectiveness of pharmaceutical-based pandemic influenza mitigation strategiesAnthony T Newall, James G Wood, Noemie Oudin, et al.
Journal of Paediatrics and Child Health|August 24, 2006
Burden of severe rotavirus disease in AustraliaAnthony T Newall, Raina MacIntyre, Han Wang, et al.
Influenza and Other Respiratory Viruses|October 13, 2017
WHO guide on the economic evaluation of influenza vaccinationAnthony T Newall, Nathorn Chaiyakunapruk, Philipp Lambach, et al.
Vaccine|September 14, 2016
Passive immunization for influenza through antibody therapies, a review of the pipeline, challenges and potential applicationsErin Sparrow, Martin Friede, Mohamud Sheikh, et al.
Vaccine|November 23, 2021
Influenza-associated mortality in Australia, 2010 through 2019: High modelled estimates in 2017David J Muscatello, Allen L Nazareno, Robin M Turner, et al.
Pageof 7

Showing results (11-20 of 69) with videos related to

Sort By:
Pageof 7
Vaccine|July 14, 2012
Under-explored assumptions in influenza vaccination models: implications for the universal vaccination of childrenAnthony T Newall, Juan Pablo Dehollain, James G Wood
Pharmacoeconomics|July 31, 2009
Cost effectiveness of influenza vaccination in older adults: a critical review of economic evaluations for the 50- to 64-year age groupAnthony T Newall, Heath Kelly, Stuart Harsley, et al.
Vaccine|December 14, 2011
The cost and disease burden of pneumonia in general practice in AustraliaAmbrose Li, Anthony T Newall, Helena Britt, et al.
Vaccine|November 8, 2025
Effectiveness of maternal vaccines and long-acting monoclonal antibodies against respiratory syncytial virus disease burden in early life: a scoping review of dynamic modelling studiesAlessandra Bicego, James G Wood, Anthony T Newall, et al.
Plos One|September 12, 2013
Contact tracing of tuberculosis: a systematic review of transmission modelling studiesMatt Begun, Anthony T Newall, Guy B Marks, et al.
Emerging Infectious Diseases|February 2, 2010
Cost-effectiveness of pharmaceutical-based pandemic influenza mitigation strategiesAnthony T Newall, James G Wood, Noemie Oudin, et al.
Journal of Paediatrics and Child Health|August 24, 2006
Burden of severe rotavirus disease in AustraliaAnthony T Newall, Raina MacIntyre, Han Wang, et al.
Influenza and Other Respiratory Viruses|October 13, 2017
WHO guide on the economic evaluation of influenza vaccinationAnthony T Newall, Nathorn Chaiyakunapruk, Philipp Lambach, et al.
Vaccine|September 14, 2016
Passive immunization for influenza through antibody therapies, a review of the pipeline, challenges and potential applicationsErin Sparrow, Martin Friede, Mohamud Sheikh, et al.
Vaccine|November 23, 2021
Influenza-associated mortality in Australia, 2010 through 2019: High modelled estimates in 2017David J Muscatello, Allen L Nazareno, Robin M Turner, et al.
Pageof 7